| 000 | 01869 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513194606.0 | ||
| 264 | 0 | _c20000308 | |
| 008 | 200003s 0 0 eng d | ||
| 022 | _a1071-412X | ||
| 024 | 7 |
_a10.1128/CDLI.6.6.895-905.1999 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbrams, J T | |
| 245 | 0 | 0 |
_aSézary T-cell activating factor is a Chlamydia pneumoniae-associated protein. _h[electronic resource] |
| 260 |
_bClinical and diagnostic laboratory immunology _cNov 1999 |
||
| 300 |
_a895-905 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aAntigens, Bacterial _xgenetics |
| 650 | 0 | 4 |
_aBacterial Outer Membrane Proteins _xgenetics |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aChlamydia Infections _ximmunology |
| 650 | 0 | 4 |
_aChlamydophila pneumoniae _xgenetics |
| 650 | 0 | 4 |
_aEpidermis _ximmunology |
| 650 | 0 | 4 |
_aGene Expression Regulation, Bacterial _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKeratinocytes _xcytology |
| 650 | 0 | 4 |
_aLipopolysaccharides _ximmunology |
| 650 | 0 | 4 |
_aLymphoma, T-Cell, Cutaneous _xdrug therapy |
| 650 | 0 | 4 | _aMicroscopy, Immunoelectron |
| 650 | 0 | 4 |
_aMonocytes _ximmunology |
| 650 | 0 | 4 | _aPUVA Therapy |
| 650 | 0 | 4 |
_aReceptors, Interferon _ximmunology |
| 650 | 0 | 4 |
_aSezary Syndrome _ximmunology |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aTranscription, Genetic _ximmunology |
| 700 | 1 | _aVonderheid, E C | |
| 700 | 1 | _aKolbe, S | |
| 700 | 1 | _aAppelt, D M | |
| 700 | 1 | _aArking, E J | |
| 700 | 1 | _aBalin, B J | |
| 773 | 0 |
_tClinical and diagnostic laboratory immunology _gvol. 6 _gno. 6 _gp. 895-905 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/CDLI.6.6.895-905.1999 _zAvailable from publisher's website |
| 999 |
_c10505266 _d10505266 |
||